Risk for lung cancer in workers exposed to benzidine and/or beta-naphthylamine: a protocol for systematic review and meta-analysis

详细信息    查看全文

• 作者：Kimiko Tomioka (3)
  Keigo Saeki (3)
  Kenji Obayashi (3)
  Yuu Tanaka (4)
  Norio Kurumatani (3)
  
  3. Department of Community Health and Epidemiology ; Nara Medical University ; Shijo-cho 840 ; Kashihara City ; Nara ; 634-8521 ; Japan
  4. Department of Anesthesiology ; Nara Medical University ; Shijo-cho 840 ; Kashihara City ; Nara ; Japan
  
• 关键词：Benzidine ; Beta ; naphthylamine ; Lung cancer ; Mortality ; Incidence ; Occupational exposure ; Systematic review ; Meta ; analysis ; Protocol
• 刊名：Systematic Reviews
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：3
• 期：1
• 全文大小：231 KB
• 参考文献：Chemical agents and related occupations. A review of human carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100F. IARC, Lyon, pp. 53-63
  Chemical agents and related occupations. A review of human carcinogens. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100F. IARC, Lyon, pp. 83-92
  1. Axtell, CD, Ward, EM, McCabe, GP, Schulte, PA, Stern, FB, Glickman, LT (1998) Underlying and multiple cause mortality in a cohort of workers exposed to aromatic amines. Am J Ind Med 34: pp. 506-511 CrossRef
  2. Bulbulyan, MA, Figgs, LW, Zahm, SH, Savitskaya, T, Goldfarb, A, Astashevsky, S, Zaridze, D (1995) Cancer incidence and mortality among beta-naphthylamine and benzidine dye workers in Moscow. Int J Epidemiol 24: pp. 266-275 CrossRef
  3. Cassidy, LD, Youk, AO, Marsh, GM (2003) The Drake Health Registry Study: cause-specific mortality experience of workers potentially exposed to beta-naphthylamine. Am J Ind Med 44: pp. 282-290 CrossRef
  4. Morinaga, K, Oshima, A, Hara, I (1982) Multiple primary cancers following exposure to benzidine and beta-naphthylamine. Am J Ind Med 3: pp. 243-246 CrossRef
  5. Pira, E, Piolatto, G, Negri, E, Romano, C, Boffetta, P, Lipworth, L, McLaughlin, JK, La Vecchia, C (2010) Bladder cancer mortality of workers exposed to aromatic amines: a 58-year follow-up. J Natl Cancer Inst 102: pp. 1096-1099 CrossRef
  6. Rosenman, KD, Reilly, MJ (2004) Cancer mortality and incidence among a cohort of benzidine and dichlorobenzidine dye manufacturing workers. Am J Ind Med 46: pp. 505-512 CrossRef
  Toxicological Profile for Benzidine. U.S: Department of Health and Human Services, Public Health Service, Atlanta, GA
  7. Littlefield, NA, Nelson, CJ, Frith, CH (1983) Benzidine dihydrochloride: toxicological assessment in mice during chronic exposures. J Toxicol Environ Health 12: pp. 671-685
  8. Theiss, JC, Shimkin, MB, Weisburger, EK (1981) Pulmonary adenoma response of strain A mice to sulfonic acid derivatives of 1- and 2-naphthylamines. J Natl Cancer Inst 67: pp. 1299-1302
  9. Stoner, GD, Conran, PB, Greisiger, EA, Stober, J, Morgan, M, Pereira, MA (1986) Comparison of two routes of chemical administration on the lung adenoma response in strain A/J mice. Toxicol Appl Pharmacol 82: pp. 19-31 CrossRef
  10. Hatch, FT, Knize, MG, Colvin, ME (2001) Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency. Environ Mol Mutagen 38: pp. 268-291 CrossRef
  11. Scribner, JD, Fisk, SR, Scribner, NK (1979) Mechanisms of action of carcinogenic aromatic amines: an investigation using mutagenesis in bacteria. Chem Biol Interact 26: pp. 11-25 CrossRef
  12. Jarabek, AM, Pottenger, LH, Andrews, LS, Casciano, D, Embry, MR, Kim, JH, Preston, RJ, Reddy, MV, Schoeny, R, Shuker, D, Skare, J, Swenberg, J, Williams, GM, Zeiger, E (2009) Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization. Crit Rev Toxicol 39: pp. 659-678 CrossRef
  13. Turesky, RJ, Le Marchand, L (2001) Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines. Chem Res Toxicol 24: pp. 1169-1214 CrossRef
  14. Himmelstein, MW, Boogaard, PJ, Cadet, J, Farmer, PB, Kim, JH, Martin, EA, Persaud, R, Shuker, DE (2009) Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol 39: pp. 679-694 CrossRef
  15. Talaska, G, Al Juburi, AZ, Kadlubar, FF (1991) Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 88: pp. 5350-5354 CrossRef
  16. Talaska, G, Schamer, M, Skipper, P, Tannenbaum, S, Caporaso, N, Unruh, L, Kadlubar, FF, Bartsch, H, Malaveille, C, Vineis, P (1991) Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev 1: pp. 61-66
  17. Lin, D, Lay, JO, Bryant, MS, Malaveille, C, Friesen, M, Bartsch, H, Lang, NP, Kadlubar, FF (1994) Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect 102: pp. 11-16 CrossRef
  18. Stroup, DF, Berlin, JA, Morton, SC, Olkin, I, Williamson, GD, Rennie, D, Moher, D, Becker, BJ, Sipe, TA, Thacker, SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: pp. 2008-2012 CrossRef
  19. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG (2009) The PRISMA Group: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: pp. e1000097 CrossRef
  20. Breslow, NE, Day, NE (1987) Statistical Methods in Cancer Research, vol 2. The Design and Analysis of Cohort Studies. IARC Scientific Publications, Lyon
  21. Checkoway, H, Pearce, N, Dement, JM (1989) Design and conduct of occupational epidemiology studies: I. Design aspects of cohort studies. Am J Ind Med 15: pp. 363-373 CrossRef
  22. Ferlay, J, Soerjomataram, I, Ervik, M, Dikshit, R, Eser, S, Mathers, C, Rebelo, M, Parkin, DM, Forman, D, Bray, F (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France, International Agency for Research on Cancer
  23. Wells GA, Shea B, O鈥機onnell D, Peterson J, Welch V, Losos M, Tugwell P: / The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 10 June 2014
  24. Alder, N, Fenty, J, Warren, F, Sutton, AJ, Rushton, L, Jones, DR, Abrams, KR (2006) Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry. Am J Epidemiol 164: pp. 405-420 CrossRef
  25. Dersimonian, R, Kacker, R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28: pp. 105-114 CrossRef
  26. Higgins, JPT, Thompson, SG, Deeks, JJ, Altman, DG (2003) Measuring inconsistency in meta-analysis. BMJ 327: pp. 557-560 CrossRef
  27. Egger, M, Davey-Smith, G, Schneider, M, Minder, C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315: pp. 629-634 CrossRef
  28. Lau, J, Antman, EM, Jimenez-Silva, J, Kupelnick, B, Mosteller, F, Chalmers, TC (1992) Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 327: pp. 248-254 CrossRef
  29. Thacker, SB (1988) Meta-analysis. JAMA 259: pp. 1685-1689 CrossRef
  30. Petitti, D (1994) Meta-analysis, Decision Analysis, and Cost Effectiveness Analysis. Oxford University Press, New York
  
• 刊物主题：Medicine/Public Health, general; Biomedicine general; Statistics for Life Sciences, Medicine, Health Sciences;
• 出版者：BioMed Central
• ISSN：2046-4053

文摘

Background Risk for lung cancer in workers exposed to benzidine (BZ) and/or beta-naphthylamine (BNA), which are well-known bladder carcinogens, has been examined in many epidemiological studies, but individual epidemiological studies generally lack the power to examine the association between BZ/BNA exposure and lung cancer. We conduct a systematic review and meta-analysis to determine the risk for lung cancer among workers exposed to BZ/BNA occupationally. Methods/design Studies will be identified by a MEDLINE, EMBASE, CDSR, and CINAHL search and by the reference lists of articles/relevant reviews. Eligible studies will be cohort and case-control studies that report occupational BZ/BNA exposure and the outcome of interest (lung cancer death/incidence). The method of meta-analysis will be used to combine standardized mortality ratios (SMRs) and/or standardized incidence ratios (SIRs) from retrospective and prospective cohort studies and odds ratios (ORs) from case-control studies. Two reviewers will independently screen articles, extract data, and assess scientific quality using standardized forms and published quality assessment tools tailored for each study design. Overall pooled risk estimates and their corresponding 95% confidence intervals (CIs) will be obtained using random effects model. This systematic review and meta-analysis will be conducted following the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines, and results will be reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. Discussion This review will identify and synthesize studies of the association between occupational BZ/BNA exposure and lung cancer. The findings will help to identify whether BZ/BNA could cause lung cancer and might indicate whether workers with exposure to BZ/BNA have a need for preventive measures against non-urological cancer besides bladder cancer. Systematic review registration PROSPERO CRD42014010250